1 |
ERBB2
| 4件: Platinum drug resistance Platinum drug resistance, Tight junction, Proteoglycans in cancer, Prostate cancer | D08108
D08108
|
Lapatinib
| 3件: 34 34, 74, 75 |
2 |
ERBB2
| 4件: Platinum drug resistance Platinum drug resistance, Tight junction, Proteoglycans in cancer, Prostate cancer | D08950
D08950
|
Neratinib
| 1件: 34 34 |
3 |
ERBB2
| 4件: Platinum drug resistance Platinum drug resistance, Tight junction, Proteoglycans in cancer, Prostate cancer | D11772
D11772
|
Tesevatinib
| 1件: 67 67 |
4 |
MAP3K5
| 7件: Platinum drug resistance Platinum drug resistance, Sphingolipid signaling pathway, Protein processing in endoplasmic reticulum, Tight junction, TNF signaling pathway, Thermogenesis, Spinocerebellar ataxia | D10988
D10988
|
Selonsertib
| 1件: 86 86 |
5 |
PIK3CA
| 26件: Platinum drug resistance Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Small cell lung cancer | D11011
D11011
|
Alpelisib
| 1件: 138 138 |
6 |
PIK3CA
| 26件: Platinum drug resistance Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Small cell lung cancer | D11158
D11158
|
Leniolisib
| 2件: 53 53, 65 |
7 |
PIK3CB
| 26件: Platinum drug resistance Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Small cell lung cancer | D11158
D11158
|
Leniolisib
| 2件: 53 53, 65 |
8 |
PIK3CD
| 26件: Platinum drug resistance Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Small cell lung cancer | D11158
D11158
|
Leniolisib
| 2件: 53 53, 65 |
9 |
PIK3CD
| 26件: Platinum drug resistance Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Small cell lung cancer | D11437
D11437
|
Parsaclisib
| 3件: 35 35, 53, 61 |
10 |
BCL2
| 9件: Platinum drug resistance Platinum drug resistance, Sphingolipid signaling pathway, Protein processing in endoplasmic reticulum, Shigellosis, Salmonella infection, Toxoplasmosis, Tuberculosis, Prostate cancer, Small cell lung cancer | D10679
D10679
|
Venetoclax
| 1件: 28 28 |
11 |
TOP2A
| 1件: Platinum drug resistance Platinum drug resistance | D00125
D00125
|
Etoposide
| 11件: 11 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 |
12 |
TOP2A
| 1件: Platinum drug resistance Platinum drug resistance | D03730
D03730
|
Dexrazoxane
| 1件: 13 13 |
13 |
TOP2A
| 1件: Platinum drug resistance Platinum drug resistance | D03899
D03899
|
Doxorubicin
| 5件: 26 26, 28, 34, 65, 331 |
14 |
TOP2A
| 1件: Platinum drug resistance Platinum drug resistance | D05522
D05522
|
Pixantrone
| 2件: 11 11, 13 |
15 |
TOP2A
| 1件: Platinum drug resistance Platinum drug resistance | D07776
D07776
|
Daunorubicin
| 1件: 65 65 |
16 |
TOP2A
| 1件: Platinum drug resistance Platinum drug resistance | D08224
D08224
|
Mitoxantrone
| 1件: 13 13 |
17 |
TOP2B
| 1件: Platinum drug resistance Platinum drug resistance | D00125
D00125
|
Etoposide
| 11件: 11 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 |
18 |
TOP2B
| 1件: Platinum drug resistance Platinum drug resistance | D03730
D03730
|
Dexrazoxane
| 1件: 13 13 |
19 |
TOP2B
| 1件: Platinum drug resistance Platinum drug resistance | D03899
D03899
|
Doxorubicin
| 5件: 26 26, 28, 34, 65, 331 |
20 |
TOP2B
| 1件: Platinum drug resistance Platinum drug resistance | D05522
D05522
|
Pixantrone
| 2件: 11 11, 13 |
21 |
TOP2B
| 1件: Platinum drug resistance Platinum drug resistance | D07776
D07776
|
Daunorubicin
| 1件: 65 65 |
22 |
TOP2B
| 1件: Platinum drug resistance Platinum drug resistance | D08224
D08224
|
Mitoxantrone
| 1件: 13 13 |
23 |
CASP9
| 9件: Platinum drug resistance Platinum drug resistance, VEGF signaling pathway, Thyroid hormone signaling pathway, Prion disease, Toxoplasmosis, Tuberculosis, Prostate cancer, Small cell lung cancer, Viral myocarditis | D11195
D11195
|
Rimiducid
| 6件: 19 19, 60, 65, 284, 285, 326 |